Advanced glycation end products induce lipogenesis: Regulation by natural xanthone through inhibition of ERK and NF-κB

Journal of Cellular Physiology

Volumn 229, Issue 12, 2014, Pages 1972-1980

  Mahali, Sidhartha K ^a   Verma, Neeharika ^a   Manna, Sunil K ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ASCORBIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGIFERIN; MITOGEN ACTIVATED PROTEIN KINASE; PYRROLIDINE DITHIOCARBAMATE; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DRUG MECHANISM; ENZYME ACTIVITY; FATTY LIVER; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; LIPID HOMEOSTASIS; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STAINING; TRANSCRIPTION REGULATION;

ANTIOXIDANTS; APOPTOSIS; DIABETES MELLITUS; FATTY LIVER; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPOGENESIS; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; OXIDATIVE STRESS; PPAR GAMMA; SIGNAL TRANSDUCTION; XANTHONES;

EID: 84906706362     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24647     Document Type: Article

References (38)

1. Akiyama TE, Sakai S, Lambert G, Nicol CJ, Matsusue K, Pimprale S, Lee YH, Ricote M, Glass CK, Brewer HB, Jr., Gonzalez FJ. 2002. Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol 22:2607-2619.
2. Chang Y, Wang J, Lu X, Thewke DP, Mason RJ. 2005. KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells. J Lipid Res 46:2624-2635.
3. Desvergne B, Michalik L, Wahli W. 2006. Transcriptional regulation of metabolism. Physiol Rev 86:465-514.
4. Ferre P, Foufelle F. 2007. SREBP-1c transcription factor and lipid homeostasis: Clinical perspective. Horm Res 68:72-82.
5. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. 2000. Inflam-aging an evolutionary perspective on immunoscenescence. Ann NY Acad Sci 908:244-254.
6. Gao Z, He O, Peng B, Chiao PJ, Ye J. 2006. Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function. J Biol Chem 281:4540-4547.
7. Green CJ, Macrae K, Fogarty S, Hardie DG, Sakamoto K, Hundal HS. 2011. Counter-modulation of fatty acid-induced pro-inflammatory nuclear factor κB signalling in rat skeletal muscle cells by AMP-activated protein kinase. Biochem J 435:463-474.
8. Hamik A, Atkins GB, Jain MK. 2005. Molecular mechanisms of diabetic vasculopathy. Drug Discov Today 2:11-17.
9. Jiang C, Ting AT, Seed B. 1997. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
10. Khaidakov M, Mitra S, Kang BY, Wang X, Kadlubar S, Novelli G, Raj V, Winters M, Carter WC, Mehta JL. 2011. Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer. PLoS ONE 6:e20277.
11. Khuhawar MY, Kandhro AJ, Khand FD. 2006. Liquid chromatographic determination of glyoxal and methylglyoxal from serum of diabetic patients using meso-stilbenediamine as derivatizing reagents. Anal Lett 39:2205-2215.
12. Konstantinopoulos PA, Vandoros GP, Sotiropoulou-Bonikou G, Kominea A, Papavassiliou AG. 2007. NF-kappaB/PPAR gamma and/or AP-1/PPAR gamma 'on/off' switches and induction of CBP in colon adenocarcinomas: Correlation with COX-2 expression. Int J Colorectal Dis 22:57-68.
13. Kotzka J, Knebel B, Haas J, Kremer L, Jacob S, Hartwig S, Nitzgen U, Muller-Wieland D. 2012. Preventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity. PLoS ONE 7:e32609.
14. Kotzka J, Lehr S, Roth G, Avci H, Knebel B, Muller-Wieland D. 2004. Insulin-activated Erk-mitogen-activated protein kinases phosphorylate sterol regulatory element-binding Protein-2 at serine residues 432 and 455 in vivo. J Biol Chem 279:22404-22411.
15. Lapolla A, Flamini R, Vedova AD, Senesi A, Reitano R, Fedele D, Basso E, Seraglia R, Traldi P. 2003. Glyoxal and methylglyoxal levels in diabetic patients: Quantitative determination by a new GC/MS method. Clin Chem Lab Med 41:1166-1173.
16. Li Y, Qi Y, Huang TH, Yamahara J, Roufogalis BD. 2008. Pomegranate flower: A unique traditional anti-diabetic medicine with dual PPAR-alpha/-gamma activator properties. Diabetes Obes Metab 10:10-17.
17. Ma KL, Ruan XZ, Powis SH, Chen Y, Moorhead JF, Varghese Z. 2008. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology 48:770-781.
18. Mahali SK, Manna SK. 2012. Beta-D-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding. Biochem Pharmacol 84:1681-1690.
19. Mahali SK, Raviprakash N, Raghavendra PB, Manna SK. 2011. Advanced glycation end products (AGEs) induce apoptosis via a novel pathway: Involvement of Ca2+ mediated by interleukin-8 protein. J Biol Chem 286:34903-34913.
20. Manna SK, Babajan B, Raghavendra PB, Raviprakash N, Sureshkumar C. 2010. Inhibiting TRAF2-mediated activation of NF-kappaB facilitates induction of AP-1. J Biol Chem 285:11617-11627.
21. Manna SK, Rangasamy T, Wise K, Sarkar S, Shishodia S, Biswal S, Ramesh GT. 2006. Long term environmental tobacco smoke activates nuclear transcription factor-kappa B, activator protein-1, and stress responsive kinases in mouse brain. Biochem Pharmacol 71:1602-1609.
22. Matsuzawa A, Ichijo H. 2005. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid Redox Signal 7:472-481.
23. Muruganandan S, Srinivasan K, Gupta S, Gupta PK, Lal J. 2005. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 97:497-501.
24. Niu Y, Li S, Na L, Feng R, Liu L, Li Y, Sun C. 2012. Mangiferin decreases plasma free fatty acids through promoting its catabolism in liver by activation of AMPK. PLoS ONE 7:e30782. DOI: 10.1371/journal.pone.0030782.
25. Odani H, Shinzato T, Matsumoto Y, Usami J, Maeda K. 1999. Increase in three alpha, beta-dicarbonyl compound levels in human uremic plasma: Specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun 256:89-93.
26. Reka AK, Goswami MT, Krishnapuram R, Standiford TJ, Keshamouni VG. 2011. Molecular cross-regulation between PPAR-γ and other signaling pathways: Implications for lung cancer therapy. Lung Cancer 72:154-159.
27. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82.
28. Sakaguchi M, Murata H, Yamamoto K, Ono T, Sakaguchi Y, Motoyama A, Hibino T, Kataoka K, Huh NH. 2011. TIRAP, an Adaptor Protein for TLR2/4, transduces a Signal from RAGE Phosphorylated upon Ligand Binding. PLoS ONE 6:e23132. DOI: 10.1371/journal.pone.0023132.
29. Sarkar A, Sreenivasan Y, Ramesh GT, Manna SK. 2004. Beta-D-Glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis. J Biol Chem 279:33768-33781.
30. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D. 1995. Advanced glycation end products interacting with their andothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395-1403.
31. Singh R, Barden A, Mori T, Beilin L. 2001. Advanced glycation end products: A review. Diabetologia. 244:129-146.
32. van Diepen JA, Wong MC, Guigas B, Bos J, Stienstra R, Hodson L, Shoelson SE, Berbee JF, Rensen PC, Romijn JA, Havekes LM, Voshol PJ. 2011. Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice. J Lipid Res 52:942-950.
33. Walczakm R, Tontonoz P. 2002. PPARadigms and PPARadoxes: Expanding roles for PPARgamma in the control of lipid metabolism. J Lipid Res 43:177-186.
34. Xue JH, Yuan Z, Wu Y, Liu Y, Zhao Y, Zhang WP, Tian YL, Liu WM, Liu Y, Kishimoto C. 2010. High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc Res 86:141-150.
35. Yamagishi S, Nakamura K, Matsui T. 2006. Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy. Curr Drug Discov Techno 3:83-88.
36. Yan D, Lehto M, Rasilainen L, Metso J, Ehnholm C, Yla-Herttuala S, Jauhiainen M, Olkkonen VM. 2007. Oxysterol binding protein induces upregulation of SREBP-1c and enhances hepatic lipogenesis. Arterioscler Thromb Vasc Biol 27:1108-1114.
37. Yuan Y, Zhao L, Chen Y, Moorhead JF, Varghese Z, Powis SH, Minogue S, Sun Z, Ruan XZ. 2011. Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitro. Am J Physiol Renal Physiol 301:F236-F243.
38. Zhang Y, Luo Z, Ma L, Xu Q, Yang Q, Si L. 2010. Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. Int J Mol Med 25:729-734.